Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.

Prospects for an AIDS vaccine: three big questions, no easy answers.

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.

Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity.

Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection.

Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication.

Long-term patency of coronary grafts with endoscopically harvested saphenous veins determined by contrast-enhanced electron beam computed tomography.

Dealing with aphasia: three simple rules.

Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease.

Vertical distance from the crest of bone to the height of the interproximal papilla between adjacent implants.

Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.

AIDS vaccine development: the long and winding road.

Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.

Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass.

Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.